3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Carcinoma, Transitional Cell
2
Breast Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Muscle Invasive Bladder Cancer (MIBC)
1
Head and Neck Neoplasms
1
HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
1
Gastric Adenocarcinoma
1
Endometrial Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Breast Cancer
1
Interventions
trastuzumab deruxtecan
1
pembrolizumab
1
Trastuzumab
1
Oxaliplatin
1
Fluorouracil
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Gastric Cancer
×
disitamab vedotin
×
90 days
×
Clear all
No trials found.